BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9368062)

  • 1. Overexpression of a single helix-loop-helix-type transcription factor, scleraxis, enhances aggrecan gene expression in osteoblastic osteosarcoma ROS17/2.8 cells.
    Liu Y; Watanabe H; Nifuji A; Yamada Y; Olson EN; Noda M
    J Biol Chem; 1997 Nov; 272(47):29880-5. PubMed ID: 9368062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6.
    Sekiya I; Tsuji K; Koopman P; Watanabe H; Yamada Y; Shinomiya K; Nifuji A; Noda M
    J Biol Chem; 2000 Apr; 275(15):10738-44. PubMed ID: 10753864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with helix-loop-helix (HLH)-type transcription factors.
    Tamura M; Noda M
    J Cell Biol; 1994 Aug; 126(3):773-82. PubMed ID: 8045940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerotome-related helix-loop-helix type transcription factor (scleraxis) mRNA is expressed in osteoblasts and its level is enhanced by type-beta transforming growth factor.
    Liu Y; Cserjesi P; Nifuji A; Olson EN; Noda M
    J Endocrinol; 1996 Dec; 151(3):491-9. PubMed ID: 8994394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An adipogenic basic helix-loop-helix-leucine zipper type transcription factor (ADD1) mRNA is expressed and regulated by retinoic acid in osteoblastic cells.
    Sawada Y; Noda M
    Mol Endocrinol; 1996 Oct; 10(10):1238-48. PubMed ID: 9121491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helix-loop-helix-type transcription factor (HES-1) is expressed in osteoblastic cells, suppressed by 1,25(OH)2 vitamin D3, and modulates 1,25(OH)2 vitamin D3 enhancement of osteopontin gene expression.
    Matsue M; Kageyama R; Denhardt DT; Noda M
    Bone; 1997 Apr; 20(4):329-34. PubMed ID: 9108352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad2 overexpression enhances Smad4 gene expression and suppresses CBFA1 gene expression in osteoblastic osteosarcoma ROS17/2.8 cells and primary rat calvaria cells.
    Li J; Tsuji K; Komori T; Miyazono K; Wrana JL; Ito Y; Nifuji A; Noda M
    J Biol Chem; 1998 Nov; 273(47):31009-15. PubMed ID: 9812998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of DERMO-1 as a member of helix-loop-helix type transcription factors expressed in osteoblastic cells.
    Tamura M; Noda M
    J Cell Biochem; 1999 Feb; 72(2):167-76. PubMed ID: 10022499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mechanism for the regulation of osteoblast differentiation: transcription of periostin, a member of the fasciclin I family, is regulated by the bHLH transcription factor, twist.
    Oshima A; Tanabe H; Yan T; Lowe GN; Glackin CA; Kudo A
    J Cell Biochem; 2002; 86(4):792-804. PubMed ID: 12210745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the PEBP2alphaA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells.
    Tsuji K; Ito Y; Noda M
    Bone; 1998 Feb; 22(2):87-92. PubMed ID: 9477230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleraxis messenger ribonucleic acid is expressed in C2C12 myoblasts and its level is down-regulated by bone morphogenetic protein-2 (BMP2).
    Liu Y; Nifuji A; Tamura M; Wozney JM; Olson EN; Noda M
    J Cell Biochem; 1997 Oct; 67(1):66-74. PubMed ID: 9328840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of basic-helix-loop-helix transcription factors in Sertoli cell differentiation: identification of an E-box response element in the transferrin promoter.
    Chaudhary J; Cupp AS; Skinner MK
    Endocrinology; 1997 Feb; 138(2):667-75. PubMed ID: 9003001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis.
    Cserjesi P; Brown D; Ligon KL; Lyons GE; Copeland NG; Gilbert DJ; Jenkins NA; Olson EN
    Development; 1995 Apr; 121(4):1099-110. PubMed ID: 7743923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient suppression of core-binding factor alpha 1 expression by basic fibroblast growth factor in rat osteoblast-like osteosarcoma ROS17/2.8 cells.
    Tsuji K; Noda M
    J Bone Miner Metab; 2001; 19(4):213-9. PubMed ID: 11448013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The muscle transcription factor MyoD promotes osteoblast differentiation by stimulation of the Osterix promoter.
    Hewitt J; Lu X; Gilbert L; Nanes MS
    Endocrinology; 2008 Jul; 149(7):3698-707. PubMed ID: 18372333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel suppressive vitamin D response sequence in the 5'-flanking region of the murine Id1 gene.
    Ezura Y; Tournay O; Nifuji A; Noda M
    J Biol Chem; 1997 Nov; 272(47):29865-72. PubMed ID: 9368060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the rat osteocalcin basal promoter in osteoblastic cells is dependent upon homeodomain and CP1 binding motifs.
    Towler DA; Bennett CD; Rodan GA
    Mol Endocrinol; 1994 May; 8(5):614-24. PubMed ID: 7914673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage.
    Lee MS; Lowe GN; Strong DD; Wergedal JE; Glackin CA
    J Cell Biochem; 1999 Dec; 75(4):566-77. PubMed ID: 10572240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors.
    Funato N; Ohtani K; Ohyama K; Kuroda T; Nakamura M
    Mol Cell Biol; 2001 Nov; 21(21):7416-28. PubMed ID: 11585922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the basic helix-loop-helix transcription factor, scleraxis, in the regulation of Sertoli cell function and differentiation.
    Muir T; Sadler-Riggleman I; Skinner MK
    Mol Endocrinol; 2005 Aug; 19(8):2164-74. PubMed ID: 15831523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.